Romosozumab in osteoporosis: Considerable added benefit for women after menopause
Romosozumab is a bone-forming monoclonal antibody used in women after menopause for the treatment of severe osteoporosis if there is a high risk of bone fractures. Having been granted approval for this therapeutic indication ...
Jun 15, 2020
0
1